n-methylnicotinamide chloride
Small moleculeexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00758303)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- n-methylnicotinamide chloride
- tria-662
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02008084 | Phase 2 | Dec 1, 2013 | Cortria Corporation, University of Montreal |
| NCT01809301 | Phase 1 | Mar 1, 2013 | Cortria Corporation, Pharmena, PPD |
| NCT01930240 | Phase 1 | Nov 1, 2007 | Cortria Corporation |
| NCT00758303 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2007 | Cortria Corporation, University of Montreal |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cortria Corporation | For profit | 4 | 4 | 3 | 2007 |
| University of Montreal | Academic/Hospital | 2 | 0 | 2 | 2007 |
| Pharmena | For profit | 1 | 0 | 1 | 2013 |
| PPD | For profit | 1 | 0 | 1 | 2013 |
4 organizations
Page 1 / 1